Arkema SA (OTCMKTS:ARKAY) Short Interest Down 75.8% in July

Key Points

• Arkema’s short interest fell 75.8% in July to 418 shares, representing 0.0% of shares outstanding and just 0.1 days to cover.
• The company reported quarterly EPS of $1.98, beating estimates of $1.86, while revenue of $2.79 billion fell short of the $2.86 billion consensus forecast.
• Analyst sentiment remains cautious, with one Buy, five Hold, and two Sell ratings, resulting in a consensus rating of “Reduce.”

Arkema SA (OTCMKTS:ARKAY - Get Free Report) was the target of a large drop in short interest in July. As of July 31st, there was short interest totaling 418 shares, a drop of 75.8% from the July 15th total of 1,729 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 2,816 shares, the days-to-cover ratio is presently 0.1 days.

Arkema Trading Down 0.0%

OTCMKTS:ARKAY opened at $71.81 on Thursday. Arkema has a 52-week low of $56.28 and a 52-week high of $79.36. The company has a quick ratio of 1.64, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The stock has a fifty day simple moving average of $65.98 and a 200-day simple moving average of $67.85. The company has a market capitalization of $5.46 billion, a PE ratio of 247.62 and a beta of 0.85.

Arkema (OTCMKTS:ARKAY - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The basic materials company reported $1.98 EPS for the quarter, beating analysts' consensus estimates of $1.86 by $0.12. Arkema had a net margin of 0.67% and a return on equity of 4.27%. The firm had revenue of $2.79 billion for the quarter, compared to analysts' expectations of $2.86 billion. On average, equities research analysts expect that Arkema will post 3.67 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently commented on ARKAY. The Goldman Sachs Group downgraded shares of Arkema from a "buy" rating to a "neutral" rating in a report on Monday, June 8th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Arkema in a report on Tuesday, June 23rd. Sanford C. Bernstein raised Arkema from a "strong sell" rating to a "hold" rating in a research note on Monday, April 20th. Kepler Capital Markets cut Arkema from a "hold" rating to a "strong sell" rating in a report on Thursday, May 7th. Finally, Berenberg Bank cut Arkema from a "strong-buy" rating to a "hold" rating in a report on Monday, April 20th. One research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Reduce".

About Arkema

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total's chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema's operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source